Process Development for Production of Viral Vaccines and Vectors
Products
Information
Process Development for API Production, Fill/Finish and Secondary Packaging- Cell line development - Transfer of customer technologies -Upstream / Downstream -iCellis Fermenter: development of scalable upstream and downstream technologies for adherent cells with higher yield.Major advantage for development of safe live viral vaccines using non-tumorigenic cell lines - Formulation Development - Stability Evaluation - Process Development for API production- Development and qualification of own seed cell banks for vaccine manufacturing, GMP cell lines Vero and DF-1, Duck cell line (AGE-1) Contact us for more information
Distribution Areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
GermanyUnited States
All categories
Sera and VaccinesBiopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)APIs (Active Pharmaceutical Ingredients)Cell & Gene therapyInnovative APIsProductsServices
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)APIs (Active Pharmaceutical Ingredients)
